Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $2.6 million.

  • Upstream Bio's Share-based Compensation rose 3923.78% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 10951.17%. This contributed to the annual value of $6.0 million for FY2024, which is 7519.7% up from last year.
  • Per Upstream Bio's latest filing, its Share-based Compensation stood at $2.6 million for Q3 2025, which was up 3923.78% from $2.6 million recorded in Q2 2025.
  • Upstream Bio's Share-based Compensation's 5-year high stood at $2.6 million during Q1 2025, with a 5-year trough of $643000.0 in Q1 2024.
  • In the last 3 years, Upstream Bio's Share-based Compensation had a median value of $1.9 million in 2024 and averaged $1.7 million.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Share-based Compensation was 30979.78% (2025), while the steepest drop was 3923.78% (2025).
  • Upstream Bio's Share-based Compensation (Quarter) stood at $813000.0 in 2023, then skyrocketed by 156.58% to $2.1 million in 2024, then rose by 24.35% to $2.6 million in 2025.
  • Its Share-based Compensation stands at $2.6 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.6 million for Q1 2025.